About Medios AG
Medios AG is a company based in Berlin (Germany) founded in 2016. It operates as a B2B. Medios AG has completed 3 acquisitions, including Ceban, Ceban Pharmaceuticals and Medios. Medios AG offers products and services including Specialty Pharma Services and Advanced Therapies. Medios AG operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Berlin, Germany
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medios Ag
-
Annual Revenue
$1.95 B (USD)5.51as on Dec 31, 2024
-
Net Profit
$13.04 M (USD)-33.29as on Dec 31, 2024
-
EBITDA
$62.17 M (USD)19.82as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Ceban
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medios AG
Medios AG is a publicly listed company on the XETR with ticker symbol ILM1 in Germany, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medios AG
Medios AG offers a comprehensive portfolio of products and services, including Specialty Pharma Services and Advanced Therapies.
Provides innovative drug therapies for pharmacies and doctors
Offers biotechnological precision medicine solutions
Funding Insights of Medios AG
Detailed funding history for Medios AG
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medios AG
Medios AG has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Ceban, Ceban Pharmaceuticals and Medios.
Investment portfolio details for Medios AG
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Compounding pharmacy services are offered independently in Breda.
|
Locked | Locked | 2004 | Locked | |
|
Pharmaceutical products are distributed by Ceban Pharmaceuticals.
|
Locked | Locked | 1980 | Locked | |
|
Diversified drugs are distributed by Blisterzentrum Baden in Germany.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Medios AG
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Medios AG
Detailed financials for Medios AG
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medios Ag Comparisons
Peer comparison for Medios AG
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medios AG
Medios AG operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Medios AG
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medios Ag
Complete news archive for Medios AG
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medios AG
Medios AG was founded in 2016.
Medios AG is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Annual revenue of Medios AG is $1.95B as on Dec 31, 2024.
Medios AG, based in Berlin, Germany, is a market leader in Specialty Pharma, ensuring innovative drug therapies reach people across Europe. They offer services from drug supply to patient-specific treatments for pharmacies, doctors, pharmaceutical companies, and clinical study operators. Additionally, they focus on advanced biotechnological precision medicine, emphasizing sustainability and corporate values while serving healthcare professionals and investors.
Medios AG's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Medios AG offers Specialty Pharma Services and Advanced Therapies.
Yes, Medios AG is publicly traded on XETR under the ticker symbol ILM1.
Medios AG has made 3 acquisitions, including Ceban, Ceban Pharmaceuticals, and Medios.
The ticker symbol of Medios AG is ILM1 on XETR.